Less Ads, More Data, More Tools Register for FREE

Pin to quick picksXaar Regulatory News (XAR)

Share Price Information for Xaar (XAR)

Share Price is delayed by 15 minutes
Get Live Data
145.00    3.00 (2.11%)
Bid:
140.50
Ask:
144.50
Spread: 4.00 (2.847%)
Market Cap: £113.79m
XAR Live PriceLast checked at - London Stock Exchange

Intraday Xaar Share Chart

PACKAGING PROGRESS UPDATE

3 Oct 2013 07:00

RNS Number : 6006P
Xaar PLC
03 October 2013
 



 

3 October 2013

 

 

Xaar plc

 

 

PACKAGING PROGRESS UPDATE

 

 

Xaar plc ("Xaar", "the Group" or "the Company"), the inkjet printing technology Group headquartered in Cambridge, is pleased to issue an update on recent progress made in developing new opportunities in the packaging sector.

 

Xaar's market leading technology is at the heart of multiple innovative digital inkjet packaging solutions which were launched or demonstrated by Xaar's OEM partners at major exhibitions during September 2013.

 

· At Print 13 (8-12th September, Chicago) FFEI Ltd, a leading developer, manufacturer and supplier of digital imaging solutions, launched its new-generation Graphium digital UV inkjet printer. The product will be distributed by Fujifilm in both the USA and Europe. Xaar 1001 printheads were specified by FFEI to deliver the high productivity, reliability and quality that customers require for label, packaging and speciality print applications.

 

· At DRINKTEC (16-20th September 2013, Munich) four of Xaar's partner OEMs publicly demonstrated for the first time innovative "direct-to-shape" digital printing solutions. The four OEMs demonstrated systems which enable full colour images and text to be digitally printed directly onto glass, PET and metal containers, creating significant efficiencies through reductions in materials and inventory, improving time to market and eliminating many of the costs associated with using labels or sleeves. In addition, this technology allows digital decoration of irregular-shaped and textured containers which can pose a challenge for traditional labels and sleeves. It is expected that these offerings will now undergo a number of field trials which, if successful, will lead to the commercialisation of the technology.

 

· At Labelexpo Europe (24-27th September 2013, Brussels), Xaar's partner OEMs including ALS Engineering, Durst, EFI Jetrion, FFEI/Fujifilm, INX International, JF Machines and Stork Prints, all demonstrated their latest Xaar 1001-enabled labelling solutions which range from stand-alone entry-level systems for late-stage overprinting, to fully integrated systems for in-line graphics digital printing and finishing.

 

For further detail on these and other developments please go to www.xaar.com/news.aspx to access Xaar's latest news releases.

 

Ian Dinwoodie, Xaar's Chief Executive, commented:

 

"It is pleasing to see the progress being made in this significant market. Digital print of full colour graphic labels is clearly gaining traction in the packaging industry as evidenced by the strength of our OEMs' product line-up recently exhibited. The first public 'direct-to-shape' demonstrations clearly created an industry buzz, and we look forward to our partners moving through their field trials and into commercialisation. Whilst this recent activity is not expected to have any material impact on Xaar's 2013 financial results, the positive feedback received reinforces the potential for Xaar's technology to create transformational and disruptive solutions across multiple discrete markets".

 

END

 

 

 

Xaar plc:

01223-423663

Ian Dinwoodie, Chief Executive

Alex Bevis, Finance Director

Bankside Consultants:

020-7367-8888

Simon Bloomfield

Fiona Scholes

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRAFSAESEFDSESS
Date   Source Headline
2nd Jun 202612:58 pmRNSTotal Voting Rights
28th May 20269:18 amRNSResult of AGM
6th May 20267:00 amRNSDirector/PDMR Shareholding
5th May 202611:36 amRNSHolding(s) in Company
30th Apr 20264:44 pmRNSHolding(s) in Company
16th Apr 20269:00 amRNSPublication of Annual Report and Notice of AGM
1st Apr 20263:43 pmRNSHolding(s) in Company
24th Mar 20267:05 amRNSFinal Results
23rd Mar 20263:33 pmRNS-RInvestor Presentation via Investor Meet Company
2nd Mar 20262:44 pmRNSTotal Voting Rights
14th Jan 20267:00 amRNSTrading Statement
5th Jan 202612:28 pmRNSTotal Voting Rights
5th Dec 20251:15 pmRNSHolding(s) in Company
1st Dec 202512:15 pmRNSTotal Voting Rights
24th Nov 202511:00 amRNSDirector/PDMR Shareholding
3rd Nov 20252:00 pmRNSTotal Voting Rights
21st Oct 20254:15 pmRNSDirector/PDMR Shareholding
13th Oct 20253:20 pmRNSHolding(s) in Company
2nd Oct 202511:10 amRNSDirector/PDMR Shareholding
2nd Oct 20258:50 amRNSDirector/PDMR Shareholding
1st Oct 20255:00 pmRNSDirector/PDMR Shareholding
1st Oct 20253:30 pmRNSTotal Voting Rights
1st Oct 202512:04 pmRNSTRADING UPDATE and NOTICE OF RESULTS
1st Sep 20254:30 pmRNSTotal Voting Rights
12th Aug 20257:00 amRNS2025 INTERIM RESULTS
5th Aug 20257:00 amRNSBoard changes
1st Aug 20253:45 pmRNSTotal Voting Rights
14th Jul 202510:00 amRNSNotice of Interim Results
7th Jul 20253:30 pmRNSBlock listing Interim Review
2nd Jul 20253:30 pmRNSTotal Voting Rights
30th Jun 20252:00 pmRNSDirector/PDMR Shareholding
3rd Jun 202510:00 amRNSTotal Voting Rights
28th May 20253:30 pmRNSResult of AGM
21st May 20251:00 pmRNSHolding(s) in Company
7th May 20253:30 pmRNSNotification of Transactions of Directors & PDMRs
2nd May 202510:30 amRNSTotal Voting Rights
15th Apr 20251:15 pmRNS2024 Annual Report and Notice of AGM
11th Apr 202512:00 pmRNSHolding(s) in Company
1st Apr 20254:15 pmRNSHolding(s) in Company
1st Apr 20253:30 pmRNSTotal Voting Rights
31st Mar 20253:45 pmRNSNotification of Transactions of Directors & PDMRs
31st Mar 20251:10 pmRNSHolding(s) in Company
28th Mar 202511:30 amRNSHolding(s) in Company
27th Mar 202511:00 amRNSHolding(s) in Company
25th Mar 20255:00 pmRNSNotification of Transactions of Directors & PDMRs
25th Mar 20257:00 amRNSFinal Results
5th Mar 202511:30 amRNSTotal Voting Rights
19th Feb 202510:30 amRNSHolding(s) in Company
10th Feb 202511:00 amRNSHolding(s) in Company
5th Feb 20254:00 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.